You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 65 No. 6, June 2008 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Neurological Review
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (26)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Epilepsy
 •Headache
 •Migraine
 •Neurology, Other
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Common Pathophysiologic Mechanisms in Migraine and Epilepsy

Michael A. Rogawski, MD, PhD

Arch Neurol. 2008;65(6):709-714.

Migraine and epilepsy are comorbid episodic disorders that have common pathophysiologic mechanisms. Migraine attacks, like epileptic seizures, may be triggered by excessive neocortical cellular excitability; in migraine, however, the hyperexcitability is believed to transition to cortical spreading depression rather than to the hypersynchronous activity that characterizes seizures. Some forms of epilepsy and migraine are known to be channelopathies. Mutations in the same genes can cause either migraine or epilepsy or, in some cases, both. Given the likely commonalities in the underlying cellular and molecular mechanisms, it is not surprising that some antiepileptic drugs, including valproate, topiramate, and gabapentin, are effective antimigraine agents. Ionotropic glutamate receptors play roles in both migraine and epilepsy, with NMDA receptors that are critical to cortical spreading depression of particular importance in migraine. Greater understanding of the shared mechanisms of epilepsy and migraine can provide a basis for the development of improved treatment approaches that may be applicable to both conditions.


Author Affiliation: Department of Neurology, University of California Davis School of Medicine, Sacramento.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Common Mechanisms in Migraine and Epilepsy: A Comment
Markus Schürks
Arch Neurol. 2008;65(11):1546.
EXTRACT | FULL TEXT  

Common Mechanisms in Migraine and Epilepsy: A Comment—Reply
Michael A. Rogawski
Arch Neurol. 2008;65(11):1546-1547.
EXTRACT | FULL TEXT  

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2008;65(6):695-697.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neurological Mechanisms of Migraine: Potential of the Gap-Junction Modulator Tonabersat in Prevention of Migraine
Durham and Garrett
Cephalalgia 2009;29:1-6.
ABSTRACT | FULL TEXT  

Common Mechanisms in Migraine and Epilepsy: A Comment
Schurks
Arch Neurol 2008;65:1546-1546.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.